• Home
  • Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.

Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.

Author List
Fujita M, Zhu X, Sasaki K, Ueda R, Low KL, Pollack IF, Okada H
Publication
Journal of immunology (Baltimore, Md. : 1950)
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1459204
Publication Year
2008
PubMed ID
18250414
Publication Title
Fujita M, Zhu X, Sasaki K, Ueda R, Low KL, Pollack IF, Okada H. Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma. J Immunol. 2008 Feb 15; 180(4):2089-98.